While the U.S. was among the first to issue recalls for the popular blood pressure medication valsartan, the problem has escalated globally.
Joining the U.S. in issuing recalls, the European Union, Taiwan, and South Korea have also issued recalls.
The additional recalls internationally deepen the concern that the contamination of the source of ingredients was worse than previously believed.
In late July, the U.S. Food and Drug Administration issued a recall after a manufacturing change at China’s Zhejiang Huahai Pharmaceutical Co. exposed the valsartan to the probable carcinogen N-nitrosodimethylamine (NDMA).
The chemical has been shown to be toxic for the liver and other organs and is used in lab testing and has been used as a poison.
At least 10 companies who get valsartan from the Chinese plant are on the FDA’s list of companies that have been forced to recall blood pressure medications.
If you have concern or are taking any of the medications on the list, it’s important to discuss your medication with your doctor immediately.